MicroPort

MicroPort is a multinational medical technology company developing and producing a broad portfolio of medical devices. Its focus spans diverse therapeutic areas including interventional cardiology, orthopedics, cardiac rhythm management, neurovascular intervention, structural heart disease, surgical robotics, and critical care. The company employs advanced solutions to address complex medical conditions.

Founded in Shanghai in 1998 by Zhaohua Chang and a team of engineers, MicroPort originated from the unmet need for high-quality interventional cardiology devices in the Chinese market. This led to the initial development of coronary balloons, catheters, and drug-eluting stents, forming the foundation for its subsequent technological and global expansion.

MicroPort’s products serve patients globally, with devices distributed across over 90 countries. The company's vision is to advance global patient care through innovative medical devices and technical solutions. By expanding its offerings and international presence, MicroPort aims to provide comprehensive, high-quality treatment options to a worldwide patient population.